Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Microbot Medical ( (MBOT) ).
On April 21, 2025, Microbot Medical Inc. issued 1,533,336 shares of common stock, generating approximately $2.3 million in gross proceeds. The company also announced the addition of Allison Rosefort as Vice President of Marketing and Lisa Dobbins as Director of Human Resources on April 23, 2025, bolstering its commercial leadership team in preparation for the anticipated U.S. launch of its LIBERTY Endovascular Robotic System, pending FDA clearance.
More about Microbot Medical
Microbot Medical Inc. is a pre-commercial stage medical technology company focused on redefining endovascular robotics to improve patient care globally. The company has developed the world’s first single-use, fully disposable endovascular robotic system, aiming to overcome traditional barriers to advanced robotic systems.
YTD Price Performance: 79.82%
Average Trading Volume: 3,061,802
Technical Sentiment Signal: Sell
Current Market Cap: $71.23M
See more data about MBOT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue